ArticleEco-Environment & Health2022
COPD deaths attributable to ozone in 2019 and future projections using the WHO AQG 2021 in urban China.
Article in Eco-Environment & Health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 15 citations in OpenAlex.
- Article
- Exhalation metabolomics: A new force in revealing the impact of ozone pollution on respiratory health.Eco-Environment & Health · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic obstructive pulmonary disease (COPD) is an epidemic in China. Ozone is a possible risk factor of COPD, with ozone concentrations increasing in China, despite air pollution mitigation measures that reduced particulate matter. The WHO Air Quality Guidelines (AQG) recommendations in 2021 are a turning point that formally recognizes the crucial role of indoor air pollution. We aimed to investigate the premature COPD deaths attributable to ozone in 2019, taking the WHO AQG 2021 level into account to determine the gap to bridge ozone control in China. First, we assessed ozone exposures initiated from indoor and outdoor sources by gender and age groups in 344 cities under four scenarios: 2019 as a baseline, and outdoor ozone at WHO AQG 2021 level in 2019, 2030, and 2050, respectively. Subsequently, we estimated COPD deaths attributable to ozone. The results show that the COPD deaths attributable to ozone are 77,737 in 2019, and 527, 872, 1355 if the outdoor ozone concentration is reduced to the WHO AQG 2021 level in 2019 (counterfactual scenario), 2030, and 2050, respectively in urban China. The indoor ozone sources only contribute to less than 5% of COPD deaths. A gap of 68.5 μg/m
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.